2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
VitalHub Announces the Appointment of New Board of Directors Member and Chairman of the Board
TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce two...
Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening
DENVER, April 13, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”),...
BridgeBio Pharma and Brown University Announce Partnership to Drive the Advancement of Academic Innovations in Genetically Driven Diseases into Potential Therapeutics for Patients
PALO ALTO, Calif. and PROVIDENCE, R.I., April 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO), and Brown University...
Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels
Noon & Night Introducing Noon & Night, featuring Lavender Fizz bath bombs and Omega CBD Soft Gels. TORONTO, April 13,...
Antion Biosciences to Present at Upcoming Scientific Conferences
PRESS RELEASE Antion Biosciences to Present at Upcoming Scientific Conferences - Abstract acceptance at the American Society of Gene &...
MeMed and 360Dx Bring Together International Experts for a Timely Discussion on Predicting COVID-19 Severity Using the Host Immune Response
MeMed and 360Dx Bring Together International Experts for a Timely Discussion on Predicting COVID-19 Severity Using the Host Immune Response...
Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy
Post hoc analysis showed a 46% decrease in mean lesion growth in eight patients with bilateral GA comparing treated eye...
Therma Bright Provides Update on Brazilian Performance Study of its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - April 13, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the...
Rritual Appoints Sarton Molnar-Fenton, Vice President Sales USA
Senior Executive with vast CPG Experience to Lead Sales Function, Driving Growth for the Rritual product line throughout USAVancouver, British...
WellSky® Introduces Advanced Home Health Visit Management Solution, Enabling Patient-Centered Care Planning at Scale
Leading home healthcare provider Intrepid USA leverages WellSky’s new predictive data analytics capabilities for enhanced visit utilization management OVERLAND PARK,...
Bodyport Appoints Amit Rushi as Chief Commercial Officer and Phyllis Whiteley, Ph.D. as Chair of the Board of Directors
SAN FRANCISCO--(BUSINESS WIRE)--Bodyport, the digital health company focused on the detection and management of heart disease, today announced that it...
GetWellNetwork Expands Access to Digital Health Tools Through New Mobile Experience
Expanding capabilities to personal devices provides greater options for all patients and reduces costs for providers BETHESDA, Md.--(BUSINESS WIRE)--#CareToBeGreat--GetWellNetwork, a...
Endologix LLC Announces Acquisition of PQ Bypass, Inc.
Company Expands Vascular Reach to Treat Unmet Needs of Both AAA and PAD Patients IRVINE, Calif.--(BUSINESS WIRE)--#AAA--Endologix LLC, a leader...
COVID accelerates demand for gig-driven customer support models
Report by GigCX platform provider Limitless shows customer service has helped supplement ‘gigger’ income and had a positive impact on...
Evotec Launches ‘BeLAB2122’, Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb
beLAB2122 LEVERAGES ACADEMIC INNOVATION FROM THE RHINE-MAIN-NECKAR REGION OF GERMANY EVOTEC PROVIDES ITS ALL-MODALITY PLATFORM TO VALIDATE FIRST-IN-CLASS THERAPEUTIC PROJECTS...
Psychobiotic PS128 Improves Mood and Sleep Quality in Its First Clinical Study on Anxiety and Stress
TAIPEI, TAIWAN / ACCESSWIRE / April 13, 2021 / Bened Biomedical’s psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a...
First Hospitalized COVID-19 Patient Dosed with KIN001 in Phase 2 Study
Randomized, Placebo-Controlled Phase 2 Study for Swiss Biotech Kinarus' Orally Administered Lead Candidate KIN001 in Hospitalized COVID-19 Patients First Interim...
Sona Secures Clinical Trial Authorization and Hospital Partner
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021...
Forian Inc. Announces $12 Million Private Placement of Common Stock
NEWTOWN, Pa., April 12, 2021 /PRNewswire/ -- Forian Inc. (Nasdaq:FORA), a provider of software and technology-enabled services for the healthcare and cannabis...
No One Left Behind: Finding the Way Forward for Students who are Unable to Receive the COVID-19 Vaccine
WILMINGTON, N.C., April 12, 2021 /PRNewswire/ -- Proving your COVID-19 vaccination status may be one of the easiest ways to...